Participant consumed grapefruit or grapefruit products and solutions within 3 days ahead of the primary dose of study drug. - "Our study uncovered the crucial position from the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, including OTX015 or ABBV-744, with https://lorenzowiteq.bloggactif.com/33181677/details-fiction-and-clinical-trial-recruitment-for-abbv-744-study